Regent Pacific Group Limited
0575.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$255.34M
Close$
$-0.22
126.1% downside
Current Fair Value
126.1% downsideOvervalued by 126.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $255.34 Million |
|---|---|
| Enterprise Value | $262.46 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.02 |
| Beta | 1.12 |
| Outstanding Shares | 291,815,782 |
Return
| Return on Equity | 99.69% |
|---|---|
| Return on Assets | -105.33% |
| Return on Invested Capital | -376.96% |
Valuation & Multiples
| P/E Ratio | -16.64 |
|---|---|
| PEG | 13.37 |
| Price to Sales | - |
| Price to Book Ratio | -0.84 |
| Enterprise Value to Revenue | 41.57 |
| Enterprise Value to EBIT | -56.26 |
| Enterprise Value to Net Income | -44 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | -1.22 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Regent Pacific Group Limited
17 employees
CEO: Jamie Alexander Gibson Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable f...